Jeffrey Runge - Jun 1, 2021 Form 4 Insider Report for Aditx Therapeutics, Inc. (ADTX)

Role
Director
Signature
/s/ Jeffrey W. Runge, M.D.
Stock symbol
ADTX
Transactions as of
Jun 1, 2021
Transactions value $
$29,344
Form type
4
Date filed
6/2/2021, 05:38 PM
Next filing
Oct 1, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADTX Common Stock Purchase $2.05K +700 +28% $2.94* 3.2K Jun 1, 2021 Direct
transaction ADTX Common Stock Purchase $2.06K +700 +21.88% $2.94* 3.9K Jun 1, 2021 Direct
transaction ADTX Common Stock Purchase $4.69K +1.6K +41.03% $2.93* 5.5K Jun 1, 2021 Direct
transaction ADTX Common Stock Purchase $5.86K +2K +36.36% $2.93* 7.5K Jun 1, 2021 Direct
transaction ADTX Common Stock Purchase $5.86K +2K +26.67% $2.93* 9.5K Jun 1, 2021 Direct
transaction ADTX Common Stock Purchase $8.82K +3K +31.58% $2.94* 12.5K Jun 1, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.